Skip to main content
Bangladesh Healthcare Search

Pharmaceutical company

Renata Oncology Limited — Medicine List (12 registered products)

Renata Oncology Limited has 12 registered products in the DGDA Registered Drug Products registry, covering 8 generics (active ingredients).

Top generics by Renata Oncology Limited

Generics with the most registered products of this company.

All products

Sorted by generic, then brand. Showing products 1–12 of 12.

BrandStrengthDosage formDAR no.
Erlotinib
Erloren100 mgTablet371-0003-010
Erloren150 mgTablet371-0004-010
Gefitinib
Gefiren F C Tablet250 mgTablet371-0011-010
Imatinib
Tyrokin100 mgTablet371-0010-010
Tyrokin400 mgTablet371-0005-010
Lapatinib
Laparen F C Tablet250 mgTablet371-0012-010
Lenalidomide
Ledomide10 mgCapsule371-0008-010
Ledomide25 mgCapsule371-0009-010
Methotrexate
Metorax2.5 mgTablet371-0007-010
Metorax F. C10 mgTablet371-0002-010
Nilotinib
Niloren200 mgCapsule371-0013-010
Sorafenib
Sofenib200 mgTablet371-0001-010

Frequently asked questions

How many medicines does Renata Oncology Limited have registered?
Renata Oncology Limited has 12 registered products in the DGDA registry data used on this site, covering 8 generics.
Which dosage forms are registered for Renata Oncology Limited?
By number of registered products: Tablets (9), Capsules (3).
Which generics have the most Renata Oncology Limited products?
By number of registered products: Erlotinib (2), Imatinib (2), Lenalidomide (2), Methotrexate (2), Gefitinib (1).
Does this list include prices?
No. Verified price information is not available yet, so this page shows registration details only.
What is the DAR number?
It is the registration number of the product in the DGDA (Directorate General of Drug Administration) registry.

Registration details from the DGDA Registered Drug Products registry only — no prices. A registered product is not necessarily on sale. This is not medical advice; ask a doctor or pharmacist about any medicine.

All pharmaceutical companies